Patents matching “therapy”

US 8846889

Peptide biosynthesis and pain therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8846034

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

HALOZYME, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8840905

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Sep 23, 2014 · Expires Sep 18, 2034

US 8835167

Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8834938

Use of arsenic for cancer therapy protection

The Board of Regents of the University of Texas System · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

US 8815212

Nanocarriers for imaging and therapy applications

The Board of Regents of the University of Texas System · Granted Aug 26, 2014 · Expires Aug 21, 2034

US 8815229

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

US 8809268

Combination therapy to combat helminth resistance

The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

US 8795738

Use of arsenic for cancer therapy protection

The Board of Regents of the University of Texas System · Granted Aug 5, 2014 · Expires Jul 31, 2034

US 8784802

Ischemic tissue cell therapy

Cryopraxis Criobiologia Ltda. · Granted Jul 22, 2014 · Expires Jul 17, 2034

US 8759302

Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8758723

Compositions and methods for cellular imaging and therapy

The Board of Regents of the University of Texas System · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8759301

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8748446

Halogenated compounds for photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8741880

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

Corcept Therapeutics Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

US 8734778

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

US 8709417

Combination immunotherapy for the treatment of cancer

BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8703098

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8673888

Depsipeptide for therapy of kidney cancer

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

US 8663635

N-cadherin: target for cancer diagnosis and therapy

The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

E-Therapeutics PLC · Granted Dec 24, 2013 · Expires Dec 19, 2033

US 8609843

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

US 8604011

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Dec 10, 2013 · Expires Dec 5, 2033